|
⚲
|
| Keyboard |
| Spiros Liras | |
|---|---|
| Firm | |
| Address | c/o Deep Apple Therapeutics, Inc 230 Park Avenue, Suite 2800 New York, NY 10169 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Deep Apple Therapeutics Inc | 021-426368 | Executive Officer | 5.0 M of 52.0 M |
||
| Red Queen Therapeutics Inc | 021-419494 | Director | 5.0 M of 55.0 M |
||
| Evercrisp Biosciences Inc | 021-411281 | Executive Officer | 3.5 M of 75.0 M |
||
| Apertor Pharmaceuticals Inc | 021-380841 | Executive Officer | 3.0 M of 50.0 M |
||
| Initial Therapeutics Inc | 021-371190 | Executive Officer | 3.8 M of 75.0 M |
||
| Nine Square Therapeutics Corp | 021-370079 | Executive Officer | 4.2 M of 50.0 M |
||